    <SEC-DOCUMENT>0001104659-20-043354-index.html : 20200406
    <SEC-HEADER>0001104659-20-043354.hdr.sgml : 20200406
    <ACCEPTANCE-DATETIME>20200406061120
    ACCESSION NUMBER:		0001104659-20-043354
    CONFORMED SUBMISSION TYPE:	DEF 14A
    PUBLIC DOCUMENT COUNT:		4
    CONFORMED PERIOD OF REPORT:	20200423
    FILED AS OF DATE:		20200406
    DATE AS OF CHANGE:		20200406
    EFFECTIVENESS DATE:		20200406

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Anchiano Therapeutics Ltd.
    		CENTRAL INDEX KEY:			0001534248
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		IRS NUMBER:				000000000
    		STATE OF INCORPORATION:			L3
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		DEF 14A
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-38807
    		FILM NUMBER:		20775657

    	BUSINESS ADDRESS:
    		STREET 1:		5 KIRYAT HAMADA ST
    		STREET 2:		PO BOX 45032
    		CITY:			JERUSALEM
    		STATE:			L3
    		ZIP:			9777401
    		BUSINESS PHONE:		972-2-5486555

    	MAIL ADDRESS:
    		STREET 1:		5 KIRYAT HAMADA ST
    		STREET 2:		PO BOX 45032
    		CITY:			JERUSALEM
    		STATE:			L3
    		ZIP:			9777401

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	BioCancell Ltd.
    		DATE OF NAME CHANGE:	20111104
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>DEF 14A
    <SEQUENCE>1
    <FILENAME>tm2014157-2_def14a.htm
    <DESCRIPTION>DEF 14A
    <TEXT>
    Document 1 - file: tm2014157-2_def14a.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>2
    <FILENAME>lg_anchiano.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 2 - file: lg_anchiano.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>tm2014157d2-pc_meeting1.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 3 - file: tm2014157d2-pc_meeting1.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>4
    <FILENAME>tm2014157d2-pc_meeting2.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 4 - file: tm2014157d2-pc_meeting2.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>